Fundraising Fox
/Companies
Sign in

Arima Genomics

Founded 2015 · 43 employees on LinkedIn · 2 known investors

Find your way into Arima Genomics

Sign up to see every warm intro you have to Arima Genomics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Arima Genomics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Arima Genomics develops DNA-based cancer diagnostics that combine genomic sequence with 3D genome structural information (via Hi-C sequencing) to detect fusions, rearrangements, ecDNA, and other structural drivers of cancer. It serves clinicians and biopharma partners through its Aventa clinical testing brand and translational science collaborations, using routine FFPE tumor samples to guide diagnosis and therapy selection.

BiotechHealthtechMedical Devices

Founders & leadership

Arima Genomics was founded in 2015 by Sid Selvaraj.

SSSid Selvaraj
Sid SelvarajFounder & Chief Operating OfficerSid Selvaraj is the founder and COO of Arima Genomics, which develops DNA-based cancer diagnostics that integrate genomic sequencing with 3D genome structural analysis.
TWTom Willis
Tom WillisChief Executive OfficerPartner at Illumina Ventures
ASAnthony Schmitt
Anthony SchmittSenior Vice President, ScienceSenior Vice President of Science at Arima Genomics, which develops DNA sequencing-based cancer diagnostics combining genomic analysis with 3D genome structural information to detect cancer drivers. Schmitt has expertise in developing sequencing assays and protocols for genomic analysis.
EDErin Davis
Erin DavisVice President, MarketingErin Davis holds a PhD from Stanford and has worked in molecular diagnostics (including roles at Sequenta/Adaptive, Counsyl/Myriad Women's Health, and Strata Oncology), life science tools, and consumer genomics (23andMe), bringing experience in product launches, corporate communications, and cross-functional marketing strategy.

Investors · 2

Illumina Ventureslisted by Illumina VenturesFoster City

How we know: Illumina Ventures's portfolio page · the VCSheet dataset · Not right? Tell us

Founder mafia

2 people who came through Arima Genomics went on to found or lead other companies.

Ian QuigleyScientistFounded Leash BioWill AlaynickCo-FounderFounded NanoCellect Biomedical

Related companies · 3

IDbyDNAScalable, high throughput DNA sequencing platforms.
OupOxford University Press (OUP) provides dictionary data, language datasets, and lexical content in over 60 languages to power digital literacy tools, educational software, gaming platforms, and media experiences. The company works across reading apps, word games, quiz shows, and broadcast media to expand access to language learning and comprehension.
Active Motif

Companies working in the same space as Arima Genomics.

Non-dilutive funding · 10 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase II2023$2.1M
National Institutes of Health (NIH)National Institutes of HealthPhase II2023$1M
National Institutes of Health (NIH)National Institutes of HealthPhase II2021$2.1M
National Institutes of Health (NIH)National Institutes of HealthPhase II2021$2.1M
National Institutes of Health (NIH)National Institutes of HealthPhase II2020$2M
National Institutes of Health (NIH)National Institutes of HealthPhase II2018$1.7M
National Institutes of Health (NIH)National Institutes of HealthPhase II2017$1.8M
National Institutes of Health (NIH)National Institutes of HealthPhase I2016$290.6K
National Institutes of Health (NIH)National Institutes of HealthPhase I2016$274.1K
National Institutes of Health (NIH)National Institutes of HealthPhase ISTTR2015$729.7K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Arima Genomics do?
Arima Genomics develops DNA-based cancer diagnostics that combine genomic sequence with 3D genome structural information (via Hi-C sequencing) to detect fusions, rearrangements, ecDNA, and other structural drivers of cancer. It serves clinicians and biopharma partners through its Aventa clinical testing brand and translational science collaborations, using routine FFPE tumor samples to guide diagnosis and therapy selection.
Who founded Arima Genomics?
Arima Genomics was founded by Sid Selvaraj in 2015.
Who are Arima Genomics's investors?
Arima Genomics's investors include Berkeley Catalyst, Illumina Ventures.